NEU 1.12% $14.96 neuren pharmaceuticals limited

“The launch of DAYBUE has been one of the most successful recent...

  1. 5,797 Posts.
    lightbulb Created with Sketch. 736
    “The launch of DAYBUE has been one of the most successful recent launches in rare disease

    A flop by Culper standards….


 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.